Gapping up
In reaction to strong earnings/guidance: CRC +19.2%, CECO +19%, EXEL+14.8%, AXGN +13.5%, APEI +11.8%, LINE +11.4%, NEO +9.1%, APIC +6%,HALO +5.9%, HTZ +5.3%, XON +5%, LXRX +4.4%, JD +4.2%, FCAU +4.1%,WDAY +3.8%, SBLK +3.5%, JKS +3.1%, MBI +1.9%, AZO +1.7%, SALT +1.6%,GSL +1.4%, OPK +1.2%, BNS +1.1%
Select metals/mining stocks trading higher: MT +10.5%, BBL +5%, BHP+4.9%, RIO +4.4%, VALE +4.1%, X +2.6%, AA +2.1%
Other news: EXEL +15.1% (Exelixis and Ipsen (IPSEY) jointly announce an exclusive licensing agreement for the commercialization & further development of oncology drug Cabozantinib ), SYN +12.5% (US Patent office issues notices of allowance for 3 patent applications covering SYN-004; intended for prevention of C. difficile infection & antibiotic-associated diarrhea), FOLD +12% (sannounces 'positive' data from both of its Phase 3 studies of the oral small molecule pharmacological chaperone migalastat HCl ), TROV +6.8% (enters into an agreement with Multiplan for participation in the PHCS), PVCT +6.4% (receives patent extending protection of the PV-10 manufacturing process), TTM +5.3% (reports Feb. 2016 sales), HSC +4.7% (awarded $10 mln order from the Mexico City International Airport), FCAU +4.1% ( reports FEB US Sales up 12%), BTU+2.5% (updates on initiative to optimize liquidity and reduce leverage; files to delay form 10-K), LVS +2.2% (Macau gaming data released), VRX +1.7% ( issues statement, confirms it received a subpoena from the SEC in Q4 ),BABA +1.5% (in symp with JD earnings), TWTR +1.1% (still checking, may just be up with futures today), SNN +0.9% (concludes pension funding exercise; agreements to boost free cash flow by £50 mln in FY17 onwards)
Analyst comments: BGG +3.4% (upgraded to Strong Buy from Mkt Perform at Raymond James), RIG +1.7% (upgraded to Hold at Canaccord Genuity)
In reaction to strong earnings/guidance: CRC +19.2%, CECO +19%, EXEL+14.8%, AXGN +13.5%, APEI +11.8%, LINE +11.4%, NEO +9.1%, APIC +6%,HALO +5.9%, HTZ +5.3%, XON +5%, LXRX +4.4%, JD +4.2%, FCAU +4.1%,WDAY +3.8%, SBLK +3.5%, JKS +3.1%, MBI +1.9%, AZO +1.7%, SALT +1.6%,GSL +1.4%, OPK +1.2%, BNS +1.1%
Select metals/mining stocks trading higher: MT +10.5%, BBL +5%, BHP+4.9%, RIO +4.4%, VALE +4.1%, X +2.6%, AA +2.1%
Other news: EXEL +15.1% (Exelixis and Ipsen (IPSEY) jointly announce an exclusive licensing agreement for the commercialization & further development of oncology drug Cabozantinib ), SYN +12.5% (US Patent office issues notices of allowance for 3 patent applications covering SYN-004; intended for prevention of C. difficile infection & antibiotic-associated diarrhea), FOLD +12% (sannounces 'positive' data from both of its Phase 3 studies of the oral small molecule pharmacological chaperone migalastat HCl ), TROV +6.8% (enters into an agreement with Multiplan for participation in the PHCS), PVCT +6.4% (receives patent extending protection of the PV-10 manufacturing process), TTM +5.3% (reports Feb. 2016 sales), HSC +4.7% (awarded $10 mln order from the Mexico City International Airport), FCAU +4.1% ( reports FEB US Sales up 12%), BTU+2.5% (updates on initiative to optimize liquidity and reduce leverage; files to delay form 10-K), LVS +2.2% (Macau gaming data released), VRX +1.7% ( issues statement, confirms it received a subpoena from the SEC in Q4 ),BABA +1.5% (in symp with JD earnings), TWTR +1.1% (still checking, may just be up with futures today), SNN +0.9% (concludes pension funding exercise; agreements to boost free cash flow by £50 mln in FY17 onwards)
Analyst comments: BGG +3.4% (upgraded to Strong Buy from Mkt Perform at Raymond James), RIG +1.7% (upgraded to Hold at Canaccord Genuity)